Reverse cardio-oncology: A budding concept
Indian Heart J. 2023 Sep 27:S0019-4832(23)00163-3. doi: 10.1016/j.ihj.2023.09.004. Online ahead of print.ABSTRACTHaving established the significance of cardiovascular side-effects of anti-neoplastic drugs, present day cardio-oncology has forayed into newer territories buoyed by research into the multiple connections that exist between cardiovascular disease and cancer. An emerging concept of reverse cardio-oncology focuses on the heightened risk of cancer in patients with cardiovascular disease. Common mechanistics of cancer and heart failure (HF) like chronic inflammation and clonal haematopoesis as well as common predisp...
Source: Indian Heart J - September 29, 2023 Category: Cardiology Authors: Chhabi Satpathy Trinath Kumar Mishra Subhasish Singh Anshu Kumar Jha Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
CONCLUSIONS: The short-term clinical outcome of DCB angioplasty for de novo FP lesions was acceptable. Moreover, an RVD of <4.2 mm was an independent predictor of restenosis after DCB angioplasty.PMID:37739220 | DOI:10.1016/j.ihj.2023.09.002 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Kohei Yamaguchi Shinsuke Mori Tomoya Fukagawa Toshihiko Kishida Takahide Nakano Shigemitsu Shirai Masafumi Mizusawa Kenji Makino Yohsuke Honda Masakazu Tsutsumi Norihiro Kobayashi Masahiro Yamawaki Yoshiaki Ito Source Type: research
The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up
CONCLUSIONS: In this small RCT bifurcation study, BVS luminal dimensions were significantly smaller at 30 months, with acute strut discontinuities and late Intraluminal dismantling frequently observed, although acceptable clinical outcomes were noted at 5 years.PMID:37739221 | DOI:10.1016/j.ihj.2023.09.001 (Source: Indian Heart J)
Source: Indian Heart J - September 22, 2023 Category: Cardiology Authors: Johan Bennett Walter Desmet Christophe Dubois Source Type: research
A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation
CONCLUSION: Our data suggest that Ivabradine can be an option for rate control in rheumatic AF.PMID:37666416 | DOI:10.1016/j.ihj.2023.08.006 (Source: Indian Heart J)
Source: Indian Heart J - September 4, 2023 Category: Cardiology Authors: Arpita Katheria Aditya Kapoor Ankit Sahu Kamlesh Raut Harshit Khare Roopali Khanna Sudeep Kumar Naveen Garg Satyendra Tewari Source Type: research
A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation
CONCLUSION: Our data suggest that Ivabradine can be an option for rate control in rheumatic AF.PMID:37666416 | DOI:10.1016/j.ihj.2023.08.006 (Source: Indian Heart J)
Source: Indian Heart J - September 4, 2023 Category: Cardiology Authors: Arpita Katheria Aditya Kapoor Ankit Sahu Kamlesh Raut Harshit Khare Roopali Khanna Sudeep Kumar Naveen Garg Satyendra Tewari Source Type: research
